LifeTec Group will be in Mannheim (D) from April 19 through 22 for the 83rd Annual Meeting of the German Cardiac Society. Some 8,000 visitors are expected and we hope you’ll be one of them - and we hope we can meet! 

LifeTec Group’s Marco Stijnen, Nicky de Jonge and Marcel Wijlaars will be at the venue to support Cardiac Dimensions. This is the company that developed the ‘Carillon System’, a medical device that treats functional mitral regurgitation (FMR).

Heart failure

The valves of the heart consist of very flexible leaflets. When the valve closes, the leaflets cover the opening, preventing the blood to flow back. Functional regurgitation of the mitral valve means the membranes of that valve no longer touch everywhere, causing the valve to leak.

The ‘Carillon System’ is placed in a specific blood vessel that surrounds the mitral valve to a large extent. By controlling the curvature of the device, the diameter of the heart valve is made smaller, which fixes the leak partly or completely.

Cardiac Dimensions - Carillon Device explained


In their demonstration workshop in Mannheim, Cardiac Dimensions and their guests will place the Carillon System in hearts available on the table. This way the company can show how to place the device, and also demonstrate that the diameter of the valve decreases when the device is activated. 

Clinicians are critical people, as they should be. So they won’t just take anyone’s word for it that a visibly smaller valve diameter actually makes the heart function better. This is why LifeTec Group was invited, and asked to bring its Passive Heart biosimulator platform. 

Passive Heart biosimulator

Prof. dr. Walther tried the NeoChord procedure in LifeTec Group's Passive Heart biosimulator platform while visiting EACTS in Barcelona. In this video he shares his thoughts on the use of the platform LifeTec Group will also use in Mannheim:

Close to real

The LifeTec Group team will use deer hearts in the platform, in which a mitral valve leakage is induced. Next, clinicians can try out the implantation of a Carillon device in a wet lab workshop.

LifeTec Group’s Passive Heart biosimulator makes the hemodynamics ‘close to real’, allowing clinicians - through the use of endoscopic images - to see not only that the valve’s diameter has diminished after the procedure, but also that the valve’s leaflets close over properly again, making way for the conclusion that the valve’s function is repaired. 

See ánd measure

The hemodynamic data measured real time by the Passive Heart biosimulator platform immediately show the effect of the repair procedure: if the Carillon System lives up to the promises made by Cardiac Dimensions, the cardiac output of the heart will go up and the blood pressure values in the heart will improve at once. So clinicians will be able to see as well as measure the result of their implantation, whereas in a heart without bloodflow or pressure they would not be able to assess it properly. 

The proof of the pudding

“‘The proof of de pudding is in the eating’, as the saying goes.” LifeTec Group R&D director Marco Stijnen is very happy with the growing clientele. He is also struck by the fact that more and more international businesses, Australian/German/American Cardiac Dimensions among them, are finding their way to LifeTec Group and its close-to-real platforms. “Have clinicians become more critical? I can’t really judge, but it would seem that the old-fashioned way of sharing information, using static models and silicone models, no longer convinces clinicians.”

R&D Engineer

Marcel Wijlaars

Head of MedTech Innovation

Marco Stijnen

Relevant links and background


©2022 LifeTec Group.  Legal  Credits